MEDIZEN HUMANCARE Inc. (XKON:236340)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,900.00
-250.00 (-11.63%)
At close: Apr 17, 2026
Market Cap4.38B -36.7%
Revenue (ttm)583.88M +512.1%
Net Income-1.69B
EPS-821.00
Shares Out2.30M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume503
Average Volume999
Open2,200.00
Previous Close2,150.00
Day's Range1,900.00 - 2,200.00
52-Week Range1,300.00 - 2,990.00
Beta0.07
RSI50.77
Earnings Daten/a

About MEDIZEN HUMANCARE

MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally. Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service. The company was founded in 2012 and is based in Seoul, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2012
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 236340
Full Company Profile